EUVIMEDEUVIMED entdecken
Crossref

The potential of erythrocyte α-synuclein to differentiate dementia with Lewy bodies from Parkinson’s and Alzheimer’s diseases

Ryosuke Amagai, Ryunosuke Hosoi, Sakura Yoshioka, Taiki Maruyama, Takayuki Kawai, Soroku Yagihashi, Hitoshi Nukada, Ryuji Sakakibara, Ayako Okado-Matsumoto

The Journal of Biochemistry · 2025

DOI: 10.1093/jb/mvaf017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Biochemistry, 2025. Verfasst von Ryosuke Amagai und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Biochemistry, Department of Biology, Faculty of Science, Toho University, Miyama 2-2-1, Funabashi, Chiba 274-8510, Japan. Hauptthemen laut MEDLINE: alpha-Synuclein, Parkinson Disease, Lewy Body Disease, Alzheimer Disease. Die Arbeit nennt 63 Literaturangaben. Gefördert von: JSPS KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dementia with Lewy bodies (DLB) is the second most common neurodegenerative dementia after Alzheimer's disease (AD). Early differentiation of these disorders is crucial for managing core symptoms; however, existing biomarkers remain insufficient. DLB shares motor and cognitive symptoms with Parkinson’s disease (PD), and both are classified as synucleinopathies due to abnormal α-synuclein aggregation. Although α-synuclein is predominantly expressed in the central nervous system, it is also abundant in erythrocytes. Recent studies suggest a potential link between erythrocyte-derived α-synuclein and synucleinopathy pathology. Additionally, we previously reported that both erythrocytes and circulating medium and large extracellular vesicles (m/lEVs) in plasma from healthy subjects contain full-length and C-terminally truncated α-synuclein. In this study, we found that erythrocyte α-synuclein levels were significantly lower in DLB compared to AD, PD and healthy controls. Furthermore, α-synuclein levels in circulating m/lEVs were elevated in patients with neurodegenerative diseases. These findings provide new insights into the role of peripheral α-synuclein and suggest its potential utility as a diagnostic marker for DLB. While further validation is needed, erythrocyte-derived α-synuclein may complement nuclear medicine assessments in distinguishing DLB from other neurodegenerative disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha-SynucleinParkinson DiseaseLewy Body DiseaseAlzheimer DiseaseErythrocytesHumansAgedFemaleMaleBiomarkersDiagnosis, DifferentialAged, 80 and overMiddle Aged

Stichwörter der Autor:innen

Alzheimer's diseaseParkinson’s disease, α-synucleindementia with Lewy bodieserythrocytes

Substanzen

alpha-SynucleinBiomarkersSNCA protein, human

Autor:innen und Institutionen

  • Laboratory of Biochemistry, Department of Biology, Faculty of Science, Toho University, Miyama 2-2-1, Funabashi, Chiba 274-8510, Japan.
  • Department of Medical Research, Sakura Medical Center, Toho University, Shimoshizu 564-1, Sakura, Chiba 285-8741, Japan.
  • Department of Exploratory Medicine on Nature, Life and Man, Faculty of Medicine, Toho University, Inagecho 5-18, Inage-ku, Chiba 263-0035, Japan.
  • Division of Neurology, Department of Internal Medicine, Sakura Medical Center, Toho University, Shimoshizu 564-1, Sakura, Chiba 285-8741, Japan. Dowakai Chiba Hospital, Hasamacho 2-508, Funabashi, Chiba 274-0822, Japan…

Förderung

  • JSPS KAKENHI

Zitieren

APA

Amagai, R., Hosoi, R., Yoshioka, S., Maruyama, T., Kawai, T., Yagihashi, S., Nukada, H., Sakakibara, R., & Okado-Matsumoto, A. (2025). The potential of erythrocyte α-synuclein to differentiate dementia with Lewy bodies from Parkinson’s and Alzheimer’s diseases. The Journal of Biochemistry. https://doi.org/10.1093/jb/mvaf017

Vancouver

Amagai R, Hosoi R, Yoshioka S, Maruyama T, Kawai T, Yagihashi S, et al. The potential of erythrocyte α-synuclein to differentiate dementia with Lewy bodies from Parkinson’s and Alzheimer’s diseases. The Journal of Biochemistry. 2025. doi:10.1093/jb/mvaf017

BibTeX
@article{Amagai2025,
  author = {Amagai, Ryosuke and Hosoi, Ryunosuke and Yoshioka, Sakura and Maruyama, Taiki and Kawai, Takayuki and Yagihashi, Soroku and Nukada, Hitoshi and Sakakibara, Ryuji and Okado-Matsumoto, Ayako},
  title = {The potential of erythrocyte α-synuclein to differentiate dementia with Lewy bodies from Parkinson’s and Alzheimer’s diseases},
  journal = {The Journal of Biochemistry},
  year = {2025},
  doi = {10.1093/jb/mvaf017}
}
Kostenlos starten →